Clinical Trials Browser

Terminated × Advanced Solid Tumor × pembrolizumab × Clear all

NCT04513067 2023-12-08

A Safety Study of YQ23 in Advanced Solid Tumors Patients

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumor